Thermo Fisher Scientific's organic sales growth accelerated sequentially to 6% in the third quarter, while reported growth reached 9%, including a net 3% contribution from acquisitions and divestitures. Management raised its full-year sales growth guidance to 7%-8%.
Thermo Fisher is among the industry's best when it comes to cost control. As near-term spending is constrained, the company's margins show exceptional resilience.
Tariffs introduce uncertainty for the entire life science industry.
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Price/Earnings (Normalized) | 29.12 | 17.63 | 29.33 |
Price/Book Value | 4.69 | 2.05 | 6.81 |
Price/Sales | 5.47 | 2.93 | 6.84 |
Price/Cash Flow | 24.89 | 13.59 | 26.56 |
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Quick Ratio | 1.01 | 0.99 | 1.41 |
Current Ratio | 1.55 | 1.69 | 2.05 |
Interest Coverage | 5.57 | 7.22 | 16.08 |
|
Metric
|
TMO
|
MRK
|
A
|
|---|---|---|---|
Return on Assets (Normalized) | 8.26% | 4.75% | 13.27% |
Return on Equity (Normalized) | 17.21% | 8.32% | 24.92% |
Return on Invested Capital (Normalized) | 10.33% | 6.65% | 16.95% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Danaher Corp
DHR
| LOCK|$^TPWW< | LOCK|<!h | $164B | |||
| Agilent Technologies Inc
A
| LOCK|&$mqPFCv | LOCK|>? | $50B | |||
| IQVIA Holdings Inc
IQV
| LOCK|H%fK<H | LOCK|qmD@ | $46B | |||
| Waters Corp
WAT
| LOCK|^NKm<FB | LOCK|vF | $45B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|$PnR!VN | LOCK|HM | $44B | |||
| Illumina Inc
ILMN
| LOCK|yL&>Z@ | LOCK|@gRp | $43B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$dGg!c# | LOCK|NJ#X> | $34B | |||
| Quest Diagnostics Inc
DGX
| LOCK|!#S&L!n | LOCK|Jc#< | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|k%!<G$&m | LOCK|t^n? | $26B |
United States